Lowest Price Guaranteed
Slides
247
Last Updated
June 2025
View Count
5536
The global drug screening market, valued at USD 8.53 billion in 2024, is projected to reach USD 10.2 billion in 2025 and USD 37.31 billion by 2035, representing a CAGR of 14.1% during the forecast period.
 |
To learn more about this report, request a free sample copy
Drug screening refers to a methodology used to determine the drugs / metabolites in biological samples, such as blood, hair, saliva and urine. This testing methodology is commonly employed in different settings, including law enforcement agencies, sports organizations, healthcare facilities and workplaces to compliance with drug treatment programs. With rising prevalence of alcohol and drug consumption across the globe has increased the demand for drug screening testing solutions. Furthermore, rising drunk driving accidents worldwide have further necessitated the demand for drug screening tests for compliance with law enforcement.
Additionally, government organizations are prioritizing drug screening tests as a mandatory requirement at workplaces. Beyond law enforcement, drug screening is widely implemented in pharmaceutical and research institutions to identify potential therapeutics, such as peptide therapeutics and cancer therapeutics and develop personalized drugs. Driven by the ongoing demand, several industrial players are focusing on the development of advanced drug screening instruments, consumables and devices.
For instance, in February 2024, the Directorate General of Civil Aviation (DGCA) introduced a new fuel cell technology-based breath analyzer test to detect alcohol consumption. This test has been launched for airline personnel active in safety-sensitive roles in the aviation industry. Furthermore, several industrial players are aiming to upgrade their drug screening systems and services. For instance, in January 2025, Intelligent Bio Solutions (a medical technology company delivering intelligent and non-invasive testing solution) announced its plans for upgrading Intelligent Fingerprinting drug screening system to support multiple languages spoken across Asia-Pacific, North and South America, Europe and Middle East. Driven by the ongoing initiatives, we believe that the drug screening market is expected to grow steadily during the forecast period.
The market report provides comprehensive information on industrial players who are currently active across various segments of the industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | USD 10.2 Billion | |
| Market Size 2035 | USD 37.31 Billion | |
| CAGR (Till 2035) | 14.1% | |
| Type of Component |
|
|
| Type of Product |
|
|
| Type of Sample |
|
|
| Type of Drug |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the drug screening market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global drug screening market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of component (products and drug screening services), type of product (instruments (immunoassays analyzers, chromatography instruments, breath analyzer (fuel cell breath analyzer, semi-conductor breath analyzer and others breath analyzer)), rapid testing devices (urine testing devices (drug testing cups, dip cards, drug testing cassettes and oral fluid testing devices)), consumables (assay kits, sample collection devices, calibrators & controls and other consumables) and others), type of sample (urine samples, breath samples, oral fluid samples, hair samples and other samples), type of drug (alcohol, cannabis / marijuana, cocaine, opioids, amphetamine & methamphetamine, and others), end user (hospitals, criminal justice & law enforcement agencies, workplaces, drug treatment centers, individual users, pain management centers, schools & colleges and others), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of component, the global market is segmented into products and drugs screening services. According to the drug screening market analysis, presently the product segment holds more than 55% of the market share and the trend is likely to remain unchanged during the forecast period. This is potentially due to the increasing launch of advanced drug screening products by the industrial players for detecting drug overdosage. It is worth mentioning that this segment will continue to expand at a higher CAGR during the forecast period.
This segment highlights the distribution of global market across different type of products, such as instruments (immunoassays analyzers, chromatography instruments, breath analyzer (fuel cell breath analyzer, semi-conductor breath analyzer and others breath analyzer)), rapid testing devices (urine testing devices (drug testing cups, dip cards, drug testing cassettes and oral fluid testing devices)), consumables (assay kits, sample collection devices, calibrators & controls and other consumables) and others. Among these, the consumables segment holds the highest share (35%) of the market for drug screening. This dominance is due to the high demand for consumables, such as assay kits, calibrator & controls and collection devices for drug testing. However, the rapid testing devices segment is likely to grow at a higher CAGR during the forecast period. This can be attributed to the growing adoption of oral fluid devices for drug testing and screening with higher efficacy.
The global market is distributed across different types of samples, such as urine samples, breath samples, oral fluid samples, hair samples and other samples. Based on drug screening market share, currently the urine samples segment is dominating the market by holding 41% of overall revenue. It is worth mentioning that urine samples are easy to collect and offer comprehensive analysis of drug or substance abuse due to the presence of high amount of traces.
However, in the long run, the oral fluid samples segment is expected to register the fastest CAGR during the forecast period. Oral fluid is easy to collect and helps to detect drug concentration efficiently.
The global market is further sub-divided based on the type of drug into alcohol, cannabis / marijuana, cocaine, opioids, amphetamine & methamphetamine, and others. According to our drug screening market trends, presently cannabis / marijuana segment is dominating the market by holding 29% of the overall revenue share. This dominance is due to the widespread adoption of drug testing solutions for the detection of cannabis overdose in people. Moreover, cannabis / marijuana are the most common illegal drugs widely consumed across the globe, which further necessitated the demand for drug screening equipment. Furthermore, with rising awareness about the consequences of overdose of marijuana, such as hallucinogen and anxiety has bolstered the demand for drug testing solutions to prevent drug overdosage. Driven by the ongoing demand, this segment is likely to remain dominant and grow at a higher CAGR during the forecast period.
Based on the end user, the global market is segmented into hospitals, criminal justice & law enforcement agencies, workplaces, drug treatment centers, individual users, pain management centers, schools & colleges and other end users. Among these, drug treatment centers occupy the maximum share (31%) of the drug screening market report. This can be attributed to the availability of skilled personnel and technological support to test drug overdoses in the specialized drug treatment centers.
However, it is worth mentioning that criminal justice & law enforcement agencies and workplace segment are anticipated to register a higher CAGR during the forecast period. This lucrative growth is due to the growing acceptance of drug screening / drug testing solutions to prevent the incidence of drunk driving accidents and maintaining standard work ethics at workplace.
The global market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Presently, North America is dominating the drug screening market share by holding 37% of the overall revenue share. Several factors, such as rising prevalence of drug and alcohol over consumption cases and stringent law enforcement to prevent drunk driving are fueling the demand for drug screening systems in this region.
However, in Asia-Pacific, the market is expected to grow at a substantial CAGR during the forecast period. This can be attributed to the rising awareness about consequences associated with excessive drug consumption and the growing expansion of multinational companies has increased the demand for drug screening systems to maintain workplace safety.
The “Drug Screening Market Report: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for drug screening industrial players. The market research report lays emphasis on the drug screening products that are being developed. Key takeaways of the market report are briefly discussed below.
Presently, the market landscape is moderately competitive, featuring the presence of several well-established and new entrants. Majority of the industrial players, such as Abbott, Roche and Thermo Fisher Scientific are focusing on technological innovations to develop advanced drug screening instruments and systems with higher efficacy. In order to leverage competitive edge, the industrial players are undertaking strategic initiatives followed by latest product launch, partnerships and collaborations. For instance, in March 2025, Intelligent Bio Solutions announced the expansion of access to its innovative fingerprint drug testing in Andorra and Spain through a strategic collaboration with Detecto. As more market players continue to strengthen their product portfolio, we believe that the market will remain competitive over the forecast period.
The global market for drug screening is propelled by the rising incidence of excessive alcohol consumption and drug overdosing. It is worth mentioning that government organizations have also implemented strict law enforcement for growing alcohol and drug consumption to meet with public health measures which further necessitated the demand for drug screening instruments. Additionally, the stringent protocols for workplace safety have further underscored the requirement for drug screening systems.
Currently, several factors that are restraining the market growth include false positive / negative results and privacy concern. It is worth noting that sometime the drug screening test may provide false results or test false when the substance is present in the body. These false positives may affect the reliability of the test and may pose a risk of undetected substance use. Further, concerns about privacy rights and data protection due to extensive drug screening practices specifically in employment and other regulator settings may remain a major challenge for the market players.
The global drug screening market growth factors include technological innovations in drug screening technologies and expanding applications in healthcare industry. Presently, the market players are focusing on the development of rapid drug testing devices, such as point-of-care diagnostics, and sensors-based technologies to enhance sensitivity for more accurate results, which is expected to offer lucrative opportunities for investments in this field. Additionally, the growing expansion of drug screening solutions in healthcare industry for disease diagnosing is likely to be a key growth factor for the market. Additionally, the growing government initiatives to mitigate the risk of drug and alcohol abuse has necessitated the demand for advanced drug screening technologies.
The global drug screening market is valued at USD 10.2 billion in 2025 and is projected to reach USD 37.31 billion by 2035, expecting growth at a CAGR of 14.1% during the forecast period. This unprecedented market growth is driven by the rising technological innovations and strategic partnerships in this field. For instance, in December 2024, Case Western Reserve University’s Begun Center for Violence Prevention Research and Education entered into a partnership with Cuyahoga County Medical Examiner’s Office to launch pilot-drug testing program specifically designed to help control the overdosing trends. Driven by the ongoing initiatives, the market is expected to remain progressive during the forecast period, offering lucrative opportunities to industrial players for innovations.
Examples of key players engaged in this domain (which have also been captured in this report) include Abbott, Alfa Scientific Designs, ACM Global Laboratories, AdvaCare Pharma, CareHealth America, Clinical Reference Laboratory, Cordant Health Solutions, Drägerwerk, Intoximeters, Intoxalock, Lifeloc Technologies, Millennium Health, Omega Laboratories, OraSure Technologies, Premier Biotech, Quest Diagnostics, Roche, Sciteck, Shimadzu, Siemens Healthineers and Thermo Fisher Scientific. This market report includes an easily searchable excel database of all the companies focusing on the development of drug screening.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of drug screening. We have outlined some of these recent initiatives below.